This report summarises the epidemiology of hospitalisations with laboratory-confirmed influenza during the 2018 influenza season
The ERASE Project has created an unprecedented linked administrative database on acute rheumatic fever and rheumatic heart disease in Australia
We hypothesised that scheduling an additional (third) dose of oral human rotavirus vaccine for children aged 6 to <12 months would improve protection
Palivizumab appeared effective for reducing virologically confirmed respiratory syncytial virus in this high-risk cohort
Significant variation in practice, particularly for patients with a severe disease phenotype and antibiotic-resistant profile
There is low coverage of the multivalent M protein vaccine in our setting, emphasizing the need to reformulate the vaccine to improve coverage
We review the role of pneumococcal carriage studies for the evaluation of PCVs in LMICs and discuss optimal methods for conducting these studies
Pneumococcal nasopharyngeal carriage prevalence and density were higher in infants delivered vaginally compared with those delivered by cesarean birth
Reductions in pneumonia-coded hospital admissions in unvaccinated children predominated in non-Aboriginal children with low incidence of pneumonia
RV1 and RV5 were both effective in preventing laboratory confirmed and notified rotavirus infections among children aged <5 years